在晚期鼻癌的同时化学放射治疗期间使用他类药物
Jung-Min Yu1,2, Chia-Lun Chang3,4, Kuan-Chou Lin5,6
11Department of Cardiovascular Surgery, Taichung Tzu Chi Hospital, Taichung, Taiwan.
Journal of the National Comprehensive Cancer Network : JNCCN
|November 13, 2024
概括
在鼻癌 (NPC) 的同时化学放射治疗 (CCRT) 中使用他类药物显著改善了整体存活率 (OS) 和NPC特定存活率. 较高的他类药物剂量显示出剂量反应益处,降低死亡风险.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 鼻癌 (NPC) 是一个重大的健康问题.
- 同时化疗放射治疗 (CCRT) 是高级NPC的标准治疗方法.
- 类药物对NPC治疗结果的作用仍在调查中.
研究的目的:
- 评估他类药物使用对整体存活时间 (OS) 的影响.
- 评估他类药物使用对NPC特定存活率的影响.
- 为了确定在CCRT期间使用他素是否会影响晚期NPC患者的存活率.
主要方法:
- 采用了一种倾向分数匹配的队列研究设计.
- 数据来源于台湾癌症登记处和国家健康保险研究数据库.
- 该研究分析了在CCRT期间使用他类药物与生存结果之间的关联.
主要成果:
- 在CCRT期间使用静止剂独立地与改善的OS和NPC特定存活率有关.
- 类固醇使用显著降低了全因死亡率 (aHR=0.48) 和NPC特定死亡率 (aHR=0.43).
- 罗斯瓦斯塔丁,阿托瓦斯塔丁和洛瓦斯塔丁显示出有效性,观察到剂量反应关系.
结论:
- 在CCRT治疗NPC期间使用他丁与增强的OS和NPC特定存活率有关.
- 特定的他类药物 (罗斯瓦斯塔丁,阿托瓦斯塔丁,洛瓦斯塔丁) 可能有助于存活.
- 剂量反应效应表明,较高的他类药物使用可能会减轻NPC死亡率,这需要进一步的研究.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
174
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
174
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
148
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
148
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
538
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
538
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
456
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
456


